Recent developments on KCNQ potassium channel openers.
During the past five years, several members of the KCNQ potassium channel gene family have been identified with a high degree of CNS specificity. Within the KCNQ family, the combination of the KCNQ2/KCNQ3 proteins, and the KCNQ5/KCNQ3 arrangement has been identified as the molecular correlates of the different M-currents. Several lines of evidence are emerging demonstrating the importance of these channels in regulating neuronal excitability; for example, determination of the excitability threshold, firing properties, and responsiveness of neurons to synaptic inputs. Recent studies have shown that KCNQ openers have potential for the treatment of several CNS disorders characterized by neuronal hyperexcitability, such as migraine, epilepsy and neuropathic pain. This article reviews the recent developments of KCNQ potassium channel openers.
Wua
Yong-Jin
YJ
Department of Neuroscience Chemistry, Bristol-Myers Squibb Pharmaceutical Research Institute, 5 Research Parkway, Wallingford, Connecticut 06492, USA. yong-jin.wu@bms.com
Dworetzky
Steven I
SI
D000178:Acrylamides / Q000737:chemistry / Q000494:pharmacology; D000631:Aminopyridines / Q000737:chemistry / Q000494:pharmacology; D001549:Benzamides / Q000737:chemistry / Q000494:pharmacology; D002219:Carbamates / Q000737:chemistry / Q000494:pharmacology; D004827:Epilepsy / Q000188:drug therapy; D006801:Humans; D007211:Indoles / Q000737:chemistry / Q000494:pharmacology; D015640:Ion Channel Gating / Q000235:genetics / Q000502:physiology*; D051656:KCNQ Potassium Channels; D051657:KCNQ1 Potassium Channel; D008881:Migraine Disorders / Q000188:drug therapy; D000078183:Oxindoles; D010146:Pain / Q000188:drug therapy; D010655:Phenylenediamines / Q000737:chemistry / Q000494:pharmacology; D024642:Potassium Channels, Voltage-Gated / Q000187:drug effects* / Q000235:genetics / Q000502:physiology
D000178:Acrylamides; D000631:Aminopyridines; D001549:Benzamides; D002219:Carbamates; D007211:Indoles; D051656:KCNQ Potassium Channels; D051657:KCNQ1 Potassium Channel; C496909:KCNQ1 protein, human; D000078183:Oxindoles; D010655:Phenylenediamines; D024642:Potassium Channels, Voltage-Gated; C022960:2-oxindole; C101866:ezogabine; C034161:flupirtine